<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">geriatr</journal-id><journal-title-group><journal-title xml:lang="ru">Российский журнал гериатрической медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Geriatric Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2686-8636</issn><issn pub-type="epub">2686-8709</issn><publisher><publisher-name>Сайт издателя</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37586/2686-8636-1-2020-74-80</article-id><article-id custom-type="elpub" pub-id-type="custom">geriatr-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Сосудистое старение у пациентов пожилого возраста с метаболическим синдромом</article-title><trans-title-group xml:lang="en"><trans-title>Vascular ageing in elderly patients with metabolic syndrome</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5981-1754</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Недогода</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nedogoda</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Недогода Сергей Владимирович  — д-р мед. наук, профессор, заведующий кафедрой терапии и  эндокринологии факультета усовершенствования врачей </p><p>тел. +7(8442) 97-42-51</p><p>SPIN-код: 7005-7846</p></bio><bio xml:lang="en"><p>S.V. Nedogoda, MD, PhD, professor, Head of Internal Diseases and Endocrinology Departament</p><p>+7(8442) 97-42-51</p><p>SPIN-код: 7005-7846</p></bio><email xlink:type="simple">nedogodasv@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0662-1217</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цома</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsoma</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Цома Вера Владимировна  — канд. мед. наук, доцент кафедры терапии и  эндокринологии факультета усовершенствования врачей</p><p>телефон: +7(917) 833-27-76 </p><p>SPIN-код: 4918-3790</p></bio><bio xml:lang="en"><p>V.V. Tsoma, MD, PhD, associate professor, Internal Diseases and Endocrinology Department</p><p>+7(917) 833-27-76</p><p>SPIN-код: 4918-3790</p></bio><email xlink:type="simple">vtsoma38@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6740-8321</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чумачек</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Chumachek</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чумачек Елена Валерьевна  — канд. мед. наук, ассистент кафедры терапии и  эндокринологии факультета усовершенствования врачей</p><p>телефон: +7(917) 339-1384 </p><p>SPIN-код: 6298-2220</p></bio><bio xml:lang="en"><p>E.V. Chumachek, MD, PhD, associate professor, Internal medicine and endocrinology Departament</p><p>+7(917) 339-1384</p><p>SPIN-код: 6298-2220</p></bio><email xlink:type="simple">elena-chumachek@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0646-5824</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смирнова</surname><given-names>В. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Smirnova</surname><given-names>V. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Смирнова Виктория Олеговна  — ассистент кафедры терапии и  эндокринологии факультета усовершенствования врачей</p><p>телефон: +7(902) 096-44-65</p><p>SPIN-код: 4601-9910</p></bio><bio xml:lang="en"><p>V.O. Smirnova, assistant fellow, Internal Diseases and Endocrinology Departament</p><p>+7(902) 096-44-65</p><p>SPIN-код: 4601-9910</p></bio><email xlink:type="simple">3asabird@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3285-4265</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Палашкин</surname><given-names>Р. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Palashkin</surname><given-names>R. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Палашкин Роман Витальевич — аспирант кафедры терапии и эндокринологии факультета усовершенствования врачей</p><p>телефон: +7(927) 538-6971</p><p>SPIN-код: 6481-1370</p></bio><bio xml:lang="en"><p>R.V. Palashkin, PhD-student, Internal Diseases and Endocrinology Departament</p><p>+7(927) 538-6971</p><p>SPIN-код: 6481-1370</p></bio><email xlink:type="simple">oldgodlor@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Федеральное государственное бюджетное образовательное учреждение высшего образования «Волгоградский государственный медицинский университет» Министерства здравоохранения Российской Федерации<country>Россия</country></aff><aff xml:lang="en">Volgograd State Medical University, Department of Therapy and Endocrinology of the Faculty of Medical Excellence<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>22</day><month>02</month><year>2020</year></pub-date><volume>0</volume><issue>1</issue><fpage>74</fpage><lpage>80</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Недогода С.В., Цома В.В., Чумачек Е.В., Смирнова В.О., Палашкин Р.В., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Недогода С.В., Цома В.В., Чумачек Е.В., Смирнова В.О., Палашкин Р.В.</copyright-holder><copyright-holder xml:lang="en">Nedogoda S.V., Tsoma V.V., Chumachek E.V., Smirnova V.O., Palashkin R.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.geriatr-news.com/jour/article/view/8">https://www.geriatr-news.com/jour/article/view/8</self-uri><abstract><p>Старение сосудов связано с увеличением артериальной жесткости, ремоделированием сосудов, а также с увеличением скорости распространения пульсовой волны. Этот процесс может быть ускорен кумулятивным воздействием различных факторов, которые повреждают артериальную стенку: артериальная гипертензия, гипергликемия, дислипидемия, курение и т.д. В настоящее время отсутствуют убедительные данные о преимущественном влиянии тех или иных компонентов метаболического синдрома, оказывающих наибольшее влияние на ускорение сосудистого старения у пациентов пожилого возраста. В связи с этим было проведено неинтервенционное исследование, целью которого стал расчет сосудистого возраста и его сопоставление с паспортным у пациентов старше 65 лет с метаболическим синдромом (МС) и ожирением, с оценкой наибольшего вклада в сосудистое старение в данной возрастной группе различных компонентов МС. Проведенное исследование показало, что в разные возрастные периоды компоненты МС имеют различный удельный вес в формировании раннего сосудистого старения.</p></abstract><trans-abstract xml:lang="en"><p>Vascular aging is associated with increased arterial stiffness, vascular remodeling, and increased pulse wave propagation rate. This process can be accelerated by cumulative exposure to various factors that damage the arterial wall: arterial hypertension, hyperglycemia, dyslipidemia, smoking, etc. At present, there is no convincing evidence of the preferential effect of certain components of metabolic syndrome that have the greatest impact on the acceleration of vascular aging in older patients. In  this regard, a  non-interactive study was conducted to  calculate vascular age and compare it with passport age in patients over 65 years of age with metabolic syndrome (MS) and obesity, assessing the greatest contribution to vascular ageing in a given age group of different MS components. The study showed that at different age periods MS components have different specific weights in the formation of early vascular aging.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>сосудистый возраст</kwd><kwd>раннее сосудистое старение</kwd><kwd>сосудистая жесткость</kwd><kwd>метаболический синдром</kwd><kwd>шкала SCORE</kwd></kwd-group><kwd-group xml:lang="en"><kwd>vascular age</kwd><kwd>early vascular aging</kwd><kwd>vascular stiffness</kwd><kwd>metabolic syndrome</kwd><kwd>SCORE scale</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Nilsson P. Early vascular aging syndrome: background and proposed definitions. Clinical Investigation. 2011; 1(11):1523–31. DOI: 10.4155/ cli.11.141.</mixed-citation><mixed-citation xml:lang="en">Nilsson P. Early vascular aging syndrome: background and proposed definitions. Clinical Investigation. 2011; 1(11):1523–31. DOI: 10.4155/ cli.11.141.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Nilsson P.M., Olsen M.H., Laurent S. Early Vascular Aging (EVA): New Directions in Cardiovascular Protection. Amsterdam: ElsevierInc. 2015:363.</mixed-citation><mixed-citation xml:lang="en">Nilsson P.M., Olsen M.H., Laurent S. Early Vascular Aging (EVA): New Directions in Cardiovascular Protection. Amsterdam: ElsevierInc. 2015:363.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Nilsson P. Early vascular aging: consequences and prevention. Vasc. Health Risk Manag. 2008; 4(3):547–552. DOI: 10.2147/VHRM.S1094.</mixed-citation><mixed-citation xml:lang="en">Nilsson P. Early vascular aging: consequences and prevention. Vasc. Health Risk Manag. 2008; 4(3):547–552. DOI: 10.2147/VHRM.S1094.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Wang M. Central arterial aging. Handbook of hypertension: arterial stiffness in hypertension. Amsterdam: Elsevier. 2006:137–60.</mixed-citation><mixed-citation xml:lang="en">Wang M. Central arterial aging. Handbook of hypertension: arterial stiffness in hypertension. Amsterdam: Elsevier. 2006:137–60.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Scuteri A., Nilsson P. M., Tzourio C., Redon J., Laurent S. Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications. Journal of hypertension. 2011; 29(8):1469–77. DOI: 10.1097/HJH.0b013e328347cc17.</mixed-citation><mixed-citation xml:lang="en">Scuteri A., Nilsson P. M., Tzourio C., Redon J., Laurent S. Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications. Journal of hypertension. 2011; 29(8):1469–77. DOI: 10.1097/HJH.0b013e328347cc17.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">O’rourke M.F., Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. Journal of the American College of Cardiology. 2007; 50(1):1– 13. DOI: 10.1016/j.jacc.2006.12.050.</mixed-citation><mixed-citation xml:lang="en">O’rourke M.F., Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. Journal of the American College of Cardiology. 2007; 50(1):1– 13. DOI: 10.1016/j.jacc.2006.12.050.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Greenwald S.E. Ageing of the conduit arteries. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland. 2007; 211(2):157–172. DOI: 10.1002/path.2101.|</mixed-citation><mixed-citation xml:lang="en">Greenwald S.E. Ageing of the conduit arteries. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland. 2007; 211(2):157–172. DOI: 10.1002/path.2101.|</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Laurent S., Boutouyrie P. The structural factor of hypertension: large and small artery alterations. Circulation research. 2015;116(6):1007–1021. DOI: 10.1161/CIRCRESAHA.116.303596.</mixed-citation><mixed-citation xml:lang="en">Laurent S., Boutouyrie P. The structural factor of hypertension: large and small artery alterations. Circulation research. 2015;116(6):1007–1021. DOI: 10.1161/CIRCRESAHA.116.303596.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Vlachopoulos C., Aznaouridis K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. Journal of the American College of Cardiology. 2010;.55(13):1318–27. DOI: 10.1016/j.jacc.2009.10.061.</mixed-citation><mixed-citation xml:lang="en">Vlachopoulos C., Aznaouridis K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. Journal of the American College of Cardiology. 2010;.55(13):1318–27. DOI: 10.1016/j.jacc.2009.10.061.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Vlachopoulos C., Xaplanteris P., Aboyans V., Brodmann M., Cífková R., Cosentino F., Lekakis J. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis. 2015; 241(2):507–32. DOI: 10.1016/j.atherosclerosis.2015.05.007.</mixed-citation><mixed-citation xml:lang="en">Vlachopoulos C., Xaplanteris P., Aboyans V., Brodmann M., Cífková R., Cosentino F., Lekakis J. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis. 2015; 241(2):507–32. DOI: 10.1016/j.atherosclerosis.2015.05.007.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Guimaraes Cunha P., Boutouyrie P., Nilsson P., Laurent S. Early vascular ageing (EVA): definitions and clinical applicability. Current hypertension reviews. 2017; 13(1):8–15. DOI: 10.2174/1573402113666170413094319.</mixed-citation><mixed-citation xml:lang="en">Guimaraes Cunha P., Boutouyrie P., Nilsson P., Laurent S. Early vascular ageing (EVA): definitions and clinical applicability. Current hypertension reviews. 2017; 13(1):8–15. DOI: 10.2174/1573402113666170413094319.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Li P., Wang L., Liu C. Overweightness, obesity and arterial stiffness in healthy subjects: a systematic review and meta-analysis of literature studies. Postgraduate medicine. 2017;129(2):224–30. DOI: 10.1080/00325481.2017.1268903.</mixed-citation><mixed-citation xml:lang="en">Li P., Wang L., Liu C. Overweightness, obesity and arterial stiffness in healthy subjects: a systematic review and meta-analysis of literature studies. Postgraduate medicine. 2017;129(2):224–30. DOI: 10.1080/00325481.2017.1268903.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Nordstrand N., Gjevestad E., Dinh K. N., Hofsø D., Røislien J., Saltvedt E., Hjelmesæth J. The relationship between various measures of obesity and arterial stiffness in morbidly obese patients. BMC cardiovascular disorders. 2011; 11(1):7. DOI: 10.1186/1471-2261-11-7.</mixed-citation><mixed-citation xml:lang="en">Nordstrand N., Gjevestad E., Dinh K. N., Hofsø D., Røislien J., Saltvedt E., Hjelmesæth J. The relationship between various measures of obesity and arterial stiffness in morbidly obese patients. BMC cardiovascular disorders. 2011; 11(1):7. DOI: 10.1186/1471-2261-11-7.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Strasser B., Arvandi M., Pasha E.P., Haley A.P., Stanforth P., Tanaka H. Abdominal obesity is associated with arterial stiffness in middle-aged adults. Nutrition, Metabolism and Cardiovascular Diseases. 2015;25(5):495–502. DOI: 10.1016/j.numecd.2015.01.002.</mixed-citation><mixed-citation xml:lang="en">Strasser B., Arvandi M., Pasha E.P., Haley A.P., Stanforth P., Tanaka H. Abdominal obesity is associated with arterial stiffness in middle-aged adults. Nutrition, Metabolism and Cardiovascular Diseases. 2015;25(5):495–502. DOI: 10.1016/j.numecd.2015.01.002.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Lewis C.E., McTigue K.M., Burke L.E., Poirier P., Eckel R.H., Howard B.V., Pi-Sunyer F.X. Mortality, health outcomes, and body mass index in the overweight range: a science advisory from the American Heart Association. Circulation. 2009;119(25):3263–71. DOI: 10.1161/CIRCULATIONAHA.109.192574.</mixed-citation><mixed-citation xml:lang="en">Lewis C.E., McTigue K.M., Burke L.E., Poirier P., Eckel R.H., Howard B.V., Pi-Sunyer F.X. Mortality, health outcomes, and body mass index in the overweight range: a science advisory from the American Heart Association. Circulation. 2009;119(25):3263–71. DOI: 10.1161/CIRCULATIONAHA.109.192574.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Leopold J.A. Cellular and molecular mechanisms of arterial stiffness associated with obesity. Hypertension. 2013;62(6):1003. DOI: 10.1161/HYPERTENSIONAHA.113.01872.</mixed-citation><mixed-citation xml:lang="en">Leopold J.A. Cellular and molecular mechanisms of arterial stiffness associated with obesity. Hypertension. 2013;62(6):1003. DOI: 10.1161/HYPERTENSIONAHA.113.01872.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Weisbrod R.M., Shiang T., Al Sayah L., Fry J.L., Bajpai S., Reinhart-King C.A., Seta F. Arterial stiffening precedes systolic hypertension in diet-induced obesity. Hypertension. 2013;62(6):1105–10. DOI: 10.1161/HYPERTENSIONAHA.113.01744.</mixed-citation><mixed-citation xml:lang="en">Weisbrod R.M., Shiang T., Al Sayah L., Fry J.L., Bajpai S., Reinhart-King C.A., Seta F. Arterial stiffening precedes systolic hypertension in diet-induced obesity. Hypertension. 2013;62(6):1105–10. DOI: 10.1161/HYPERTENSIONAHA.113.01744.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Luft F.C. Molecular mechanisms of arterial stiffness: new insights. Journal of the American Society of Hypertension. 2012; 6(6):436–38. DOI: 10.1016/j.jash.2012.10.004.</mixed-citation><mixed-citation xml:lang="en">Luft F.C. Molecular mechanisms of arterial stiffness: new insights. Journal of the American Society of Hypertension. 2012; 6(6):436–38. DOI: 10.1016/j.jash.2012.10.004.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Windham B.G., Griswold M.E., Farasat S.M., Ling S.M., Carlson O., Egan J.M., Najjar S.S. Influence of leptin, adiponectin, and resistin on the association between abdominal adiposity and arterial stiffness. American journal of hypertension. 2010; 23(5):501– 507. DOI: 10.1038/ajh.2010.8.</mixed-citation><mixed-citation xml:lang="en">Windham B.G., Griswold M.E., Farasat S.M., Ling S.M., Carlson O., Egan J.M., Najjar S.S. Influence of leptin, adiponectin, and resistin on the association between abdominal adiposity and arterial stiffness. American journal of hypertension. 2010; 23(5):501– 507. DOI: 10.1038/ajh.2010.8.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Singhal A., Farooqi I.S., Cole T.J., O’rahilly S., Fewtrell M., Kattenhorn M., Deanfield J. Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation. 2002; 106(15):1919–24. DOI: 10.1161/01.CIR.0000033219.24717.52.</mixed-citation><mixed-citation xml:lang="en">Singhal A., Farooqi I.S., Cole T.J., O’rahilly S., Fewtrell M., Kattenhorn M., Deanfield J. Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation. 2002; 106(15):1919–24. DOI: 10.1161/01.CIR.0000033219.24717.52.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Mahmud A., Feely J. Adiponectin and arterial stiffness. American journal of hypertension. 2005; 18(12):1543–48. DOI: 10.1016/j. amjhyper.2005.06.014.</mixed-citation><mixed-citation xml:lang="en">Mahmud A., Feely J. Adiponectin and arterial stiffness. American journal of hypertension. 2005; 18(12):1543–48. DOI: 10.1016/j. amjhyper.2005.06.014.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Störk S., Bots M. L., Angerer P., von Schacky C., Grobbee D.E., Angermann, C.E., Seufert J. Low levels of adiponectin predict worsening of arterial morphology and function. Atherosclerosis. 2007; 194(2):e147-e153. DOI: https://doi.org/10.1016/j. atherosclerosis.2006.11.044.</mixed-citation><mixed-citation xml:lang="en">Störk S., Bots M. L., Angerer P., von Schacky C., Grobbee D.E., Angermann, C.E., Seufert J. Low levels of adiponectin predict worsening of arterial morphology and function. Atherosclerosis. 2007; 194(2):e147-e153. DOI: https://doi.org/10.1016/j. atherosclerosis.2006.11.044.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Tsioufis C., Dimitriadis K., Selima M., Thomopoulos C., Mihas C., Skiadas I., Kallikazaros I. Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients. European heart journal. 2007; 28(9):1162–69. DOI: 10.1093/eurheartj/ehm089.</mixed-citation><mixed-citation xml:lang="en">Tsioufis C., Dimitriadis K., Selima M., Thomopoulos C., Mihas C., Skiadas I., Kallikazaros I. Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients. European heart journal. 2007; 28(9):1162–69. DOI: 10.1093/eurheartj/ehm089.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Cuende J.I., Cuende N., Calaveras-Lagartos J. How to calculate vascular age with the SCORE project scales: a new method of cardiovascular risk evaluation. European heart journal. 2010; 31(19):2351–58. DOI: 10.1093/eurheartj/ehq205.</mixed-citation><mixed-citation xml:lang="en">Cuende J.I., Cuende N., Calaveras-Lagartos J. How to calculate vascular age with the SCORE project scales: a new method of cardiovascular risk evaluation. European heart journal. 2010; 31(19):2351–58. DOI: 10.1093/eurheartj/ehq205.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Sutton-Tyrrell K., Najjar S.S., Boudreau R.M., Venkitachalam L., Kupelian V., Simonsick E.M., Pahor M. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation. 2005;111(25):3384–90. DOI: 10.1161/CIRCULATIONAHA.104.483628.</mixed-citation><mixed-citation xml:lang="en">Sutton-Tyrrell K., Najjar S.S., Boudreau R.M., Venkitachalam L., Kupelian V., Simonsick E.M., Pahor M. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation. 2005;111(25):3384–90. DOI: 10.1161/CIRCULATIONAHA.104.483628.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Meaume S., Benetos A., Henry O.F., Rudnichi A., Safar M.E. Aortic pulse wave velocity predicts cardiovascular mortality in subjects&gt; 70 years of age. Arteriosclerosis, thrombosis, and vascular biology. 2001;21(12):2046–50. DOI: 10.1161/hq1201.100226</mixed-citation><mixed-citation xml:lang="en">Meaume S., Benetos A., Henry O.F., Rudnichi A., Safar M.E. Aortic pulse wave velocity predicts cardiovascular mortality in subjects&gt; 70 years of age. Arteriosclerosis, thrombosis, and vascular biology. 2001;21(12):2046–50. DOI: 10.1161/hq1201.100226</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
